Related Experiment Video
Updated: Jun 25, 2025

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
MicroRNAs in microglia: deciphering their role in neurodegenerative diseases
1Thermo Fisher Scientific, Waltham, MA, United States.
Abstract:
This review presents a comprehensive analysis of the role of microRNAs in microglia and their implications in the pathogenesis of neurodegenerative diseases. Microglia, as the resident immune cells of the central nervous system (CNS), are pivotal in maintaining neural homeostasis and responding to pathological changes. Recent studies have highlighted the significance of miRNAs, small non-coding RNA molecules, in regulating microglial functions. In neurodegenerative diseases, such as Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS), dysregulated miRNA expression in microglia contributes to disease progression through various mechanisms such regulation of gene expression, as modulation of cytokine response and phagocytosis. This review synthesizes current knowledge on how miRNAs influence microglial activation, cytokine production, and phagocytic activity. Specific miRNAs, such as miR-155, are explored for their roles in modulating microglial responses in the context of neuroinflammation and neurodegeneration. The study also discusses the impact of miRNA dysregulation on the transition of microglia from a neuroprotective to a neurotoxic phenotype, a critical aspect in the progression of neurodegenerative diseases.
Insights
MicroRNAs (miRNAs) critically regulate microglia, the brain's immune cells. Their dysregulation in neurodegenerative diseases drives disease progression by altering microglial function and phenotype.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Microglia are key immune cells in the central nervous system (CNS), essential for neural homeostasis and response to injury.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are increasingly recognized for their role in cellular functions.
- Dysregulation of microglial function is implicated in the pathogenesis of various neurodegenerative diseases.
Purpose of the Study:
- To provide a comprehensive review of the role of microRNAs in microglia.
- To elucidate the implications of miRNA dysregulation in microglia for neurodegenerative disease pathogenesis.
- To synthesize current knowledge on miRNA-mediated regulation of microglial activation, cytokine production, and phagocytosis.
Main Methods:
- Literature review synthesizing current research findings.
- Analysis of studies investigating miRNA expression and function in microglia.
- Exploration of specific miRNAs (e.g., miR-155) and their impact on microglial responses.
Main Results:
- MicroRNAs significantly influence microglial activation, cytokine release, and phagocytic capabilities.
- Dysregulated miRNA expression in microglia contributes to neuroinflammation and neurodegeneration in diseases like Alzheimer's, Parkinson's, ALS, and MS.
- Specific miRNAs modulate microglial phenotype, potentially shifting them from a protective to a detrimental state.
Conclusions:
- MicroRNAs are critical regulators of microglial function with profound implications in neurodegenerative diseases.
- Targeting specific miRNAs offers potential therapeutic strategies for neurodegenerative conditions.
- Understanding miRNA-microglia interactions is crucial for developing novel treatments for CNS disorders.

